Delivery Order SPE2DB20D3505-SPE2DB25FU3V6
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D3505|SPE2DB25FT9E7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,118,963 units of Naltrexone 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,813.91 and a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, a delivery order with a firm fixed price, is for the supply of 4,564,073,510 units of the drug Naltrexone 50 mg Tablet in 100-count bottles. The contract has a ceiling value of $3,086.70 and a performance period through March 26, 2024. This award is not associated with any set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naltrexone 50 mg tablets, a medication used in the treatment of opioid and alcohol dependence. The contract has a ceiling value of $4,406.62 and a completion date of December 19, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, identified as SPE2DB22D3004|SPE2DB24FPM01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 90-count tablets of the medication Naltrexone 50 mg, with a ceiling value of $1,209.01 and an ultimate completion date of February 28, 2024. The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,565,441 units of Naltrexone 50 mg tablets, a medication used to treat opioid and alcohol dependence. The fixed-price contract has a ceiling value of $1,023.20 and an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of 60-count bottles of the drug Naltrexone 50 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $4,650.81 and a completion date of November 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,519,561 units of Naltrexone 50 mg Tablets in 60-count packages. The contract has a ceiling value of $6,710.85 and an ultimate completion date of August 21, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a key supplier of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,018.51, is a delivery order for the supply of 4,566,295,719 units of Naltrexone 50 mg tablets. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The federal contract award SPE2DB22D1106|SPE2DB25FDJR7, with a ceiling value of $2,374.86, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of 60 tablet packages of Naltrexone 50 mg. The contract has a firm fixed-price pricing type and an ultimate completion date of November 1, 2024. This award is...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHX38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,283.91, is for the delivery of Naltrexone 50 mg tablets, a medication used in the treatment of opioid and alcohol dependence. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...